Pharma Equity Group reissues H1 report after missing attachment in prior release

Reuters2026/08/14 09:15

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Pharma Equity Group reissued its Jan. 1–Jun. 30, 2026 interim report on Aug. 14 because the earlier release omitted the attachment.
H1 net loss was DKK 2.7 million, versus a restated DKK 17.6 million loss a year earlier.
Equity stood at DKK 25.8 million at June 30, 2026; cash was DKK 29,000.
Full-year 2026 guidance was maintained, with revenue seen at DKK 3-8.6 million; EBIT expected at minus DKK 5.8-11.4 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharma Equity Group A/S published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608140515OMX_____CNEWS_DA_GNW1001257614_da) on August 14, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Pharma Equity Group reissues H1 report after missing attachment in prior release

You may also like

Crypto prices